Miami Neuroscience Center At Larkin Offers Hope For Those Diagnosed With Brain Tumors
MIAMI, March 20, 2013 /PRNewswire/ -- Brain Tumors do not discriminate. A recent study by the American Brain Tumor Association revealed that brain-specific tumors are a risk at any age, but are statistically more frequent in children and older adults. Metastatic brain tumors - those that begin as a cancer elsewhere in the body and spread to the brain - are more common in adults than children. News of television icon Valerie Harper's diagnosis has renewed interest in the devastating diagnosis of Leptomeningeal Carcinomatosis. Understanding the symptoms and what to do if you or a loved one is diagnosed could make all the difference in battling the challenging disease.
Dr. Aizik L. Wolf, Medical Director for the Miami Neuroscience Center at Larkin, says it's important to understand that not all hope is lost in most cases. "When people hear the diagnosis, many believe there is nothing that can be done. It is a frightening diagnosis and I see so many patients who come to me when they have been told all hope is lost, and they have only months to live. In fact, we have revolutionary procedures combined with cutting edge technology that are effective," states the nationally acclaimed neurosurgical veteran who has performed over 7000 procedures with Gamma Knife®. The Gamma Knife® is a precise, non-invasive neurosurgical tool that is used to treat brain tumors, many of which are complex or might otherwise be considered inoperable, along with a number of other brain disorders.
Dr. Wolf understands challenges. He has developed groundbreaking applications for brain tumor treatments even as many argued they would never work. Due to his innovation and tenacity advocating for his patients, including his pioneering approach to Gamma Knife treatment for multiple brain tumors have paid off. Those same techniques are now being practiced and taught in major medical universities around the world.
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts